A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for th
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for th
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a sequential therapy with RV4104A ointment, ciclopiroxolamine cream and ciclopirox film-forming solution compared with amorolfine nail lacquer alone for the treatment of dermatophytic onychomycosis (toenail) without matrix involvement
Statut
Status :
Terminé
Type d'étude
Phase IV
Age Min.
18
Ans
Age Max.
-
Genre
Tous
Aire thérapeutique :
Dermatologie
Maladie :
Onychomycose
Traitement :
Rv4104a (Onyster)
Phase :
Phase IV
Date de début de l'étude :
10 Novembre 2008
End date :
29 Août 2011
Identifiant de l'essai :
RV4104A 2008 548
Identifiant EudraCT/CTIS :
2009-011125-14
Envoyer par email